Cyto Pulse Sciences, Inc.

Glen Burnie, MD 21061

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $4.58MM
First Award Date 04/15/03
Most Recent Award Date 08/01/08

Key Personnel

Last Name Name Awards Contact
King Alan D King 6

6 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 08/01/08 - 07/31/09

DESCRIPTION (provided by applicant): The long-term objective is the commercialization of a safe, effective, easy to use and painless polynucleotide vaccine delivery system that can be used in vaccines for biodefense against NIAID Category A, B and C pathogens. In addition to biodefense related vaccines, the Easy Vax vaccine delivery system which...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 08/01/07 - 07/31/09

DESCRIPTION (provided by applicant): The long-term objective is the commercialization of a safe, effective, easy to use and painless polynucleotide vaccine delivery system that can be used in vaccines for biodefense against NIAID Category A, B and C pathogens. In addition to biodefense related vaccines, the Easy Vax vaccine delivery system which...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 08/05/06 - 07/31/07

DESCRIPTION (provided by applicant): The long-term objective is the commercialization of a safe, effective, easy to use and painless polynucleotide vaccine delivery system that can be used in vaccines for biodefense against NIAID Category A, B and C pathogens. In addition to biodefense related vaccines, the Easy Vax vaccine delivery system which...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/05 - 06/30/06

DESCRIPTION (provided by applicant): The long-term project objective is the commercialization of a safe, effective, easy to use, and painless polynucleotide vaccine delivery system that can be used in polynucleotide vaccines for biodefense against NIAID Category A, B and C Pathogens. Polynucleotide vaccines are on the forefront of vaccine BIOHA...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/04 - 06/30/05

DESCRIPTION (provided by applicant): The long-term project objective is the commercialization of a safe, effective, easy to use, and painless polynucleotide vaccine delivery system that can be used in polynucleotide vaccines for biodefense against NIAID Category A, B and C Pathogens. Polynucleotide vaccines are on the forefront of vaccine BIOHA...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/15/03 - 01/31/04

DESCRIPTION (provided by applicant): The long-term project objective is the commercialization of a safe, effective, easy to use, and painless polynucleotide vaccine delivery system that can be used in polynucleotide vaccines for biodefense against NIAID Category A, B and C Pathogens. Polynucleotide vaccines are on the forefront of vaccine devel...